期刊文献+

重组鼠IL-28的原核表达、纯化及多克隆抗体的制备 被引量:3

Prokaryotic expression,purification of recombinant mouse interleukin-28 and production of its polyclonal antibody
下载PDF
导出
摘要 目的:获取重组鼠IL-28(m IL-28)纯化蛋白,制备多克隆抗体。方法:用PCR技术扩增鼠IL-28成熟蛋白的编码序列,克隆入原核表达载体pET-30,构建融合表达载体pET-30 a-m IL-28,转化大肠埃希菌BL21(DE3),以IPTG诱导表达IL-28融合蛋白,经镍柱亲和层析纯化,然后免疫6-8周龄鸡,制备多克隆抗体,采用ELISA检测抗体效价。结果:成功构建了表达载体pET-30 a-m IL-28,DNA序列测定结果与预期结果一致。在37℃培养条件下,IPTG诱导表达的IL-28融合蛋白进行SDS-PAGE电泳分析,发现其与融合蛋白的理论计算值一致,免疫鸡后收获抗血清,ELISA显示抗体效价具有高度特异性。结论:获得了重组鼠IL-28纯化蛋白,制备了鼠IL-28多克隆抗体,为进一步深入研究IL-28的生物活性及其应用打下基础。 Objective: To obtain purified recombinant interleukin-28 of mouse(mIL-28) and prepare its polyclonal antibody.Methods: The cDNA fragment coding for mature mIL-28 protein was amplified by PCR and cloned into vector pET-30 to construct fusion expression vector pET-30a-mIL-28.After pET-30a-mIL-28 was transformed into E.coli BL21(DE3),the bacteria were induced by IPTG.The expressed mIL-28 fusion protein was purified by Ni-NTA affinity chromatography.Six to eight weeks old chickens were immunized with the purified protein for obtaining the antiserum.The titers of antibodies were measured by ELISA. Results: The DNA sequencing showed that the expression vector pET-30a-mIL-28 was constructed successfully.After induced by IPTG,the expressed mIL-28 fusion protein in E.coli cultured at 37℃ appeared a single band on SDS-PAGE.The result of ELISA indicated that the prepared polyclonal antibody had high titer and specificity. Conclusion: The purified recombinant interleukin-28 of mouse and polyclonal antibody have been acquired.
出处 《江苏大学学报(医学版)》 CAS 2009年第6期472-474,479,共4页 Journal of Jiangsu University:Medicine Edition
基金 卫生部基金项目资助(wkj2006-02-206)
关键词 白细胞介素-28 大肠埃希菌 蛋白质纯化 抗体制备 interleukin-28 Escherichia coli protein purification antibody preparation
  • 相关文献

参考文献7

  • 1Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R [ J ]. Nature Immunol, 2003,4( 1 ) : 63 -68.
  • 2Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex [ J ]. Nature Immunol, 2003,4( 1 ) : 69 -77.
  • 3Bartlett NW, Buttigieg K, Kotenko SV, et al. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model [ J ]. J Gen Virol,2005,86( Pt 6) :1589 - 1596.
  • 4Nuc P, Nuc K. Recombinant protein production in Escherichia coli [ J ]. Postepy Biochem, 2006 ; 52 (4) : 448 -456.
  • 5Dong X, Tang B, Li J, et al. Expression and purification of intact and functional soybean ( glycine max) seed ferritin complex in Escherichia coli [ J ]. J Microbiol Biotechnol, 2008,18 (2) : 299 - 307.
  • 6Studier FW, Rosenberg AH, Dunn J J, et al. Use of T7 RNA polymerase to direct expression of cloned genes [ J]. Methods Enzymol, 1990,185:60 - 89.
  • 7Kang Y, Son MS, Hoang TT. One step engineering of T7-expression strains for protein production: increasing the host-range of the T7-expression system [ J ]. Protein Expr Purif, 2007,55 (2) :325 - 333.

同被引文献35

  • 1季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 2胡茂志,焦新安,潘志明,刘业兵,邵国青,刘秀梵.猪肺炎霉形体单克隆抗体的制备与鉴定[J].中国兽医科技,2004,34(12):60-63. 被引量:2
  • 3张庶民,祁自柏.基因工程表达蛋白包涵体的形成和纯化[J].微生物学免疫学进展,1995,23(1):52-54. 被引量:9
  • 4张哲,蒋晓飞,李敏,吕元.SHV-12型超广谱β-内酰胺酶特性的研究[J].检验医学,2006,21(1):31-34. 被引量:8
  • 5BUSH K, JACOBY G A, MEDEIROS A A. A functional classification scheme for β-lactamases and its correlation with molecular structure[J]. Antimicrobial Agents Chemotherapy, 1995,39(6) :1211-1233.
  • 6AMBLER R P. The structure of beta-lactamases[J].Philos Trans R Soc Lond B Biol Sci,1980,289(1036):321-331.
  • 7KUROKAWA H, YAGI T, SHIBATA N, et al. A SHV-derived extended-spectrum β-lactamase (SHV-24) that hydrolyzes ceftazidime through a single- amino-acid substitution (D179G) in the Ω-1oop [J]. Antimicrobial Agents Chemotherapy, 2000, 44 ( 6 ) : 1725-1727.
  • 8HAWKEY P M. Prevalence and clonality of extended- spectrum beta-lactamases in Asia [J]. Clin Microbiol Infect,2008,14(S1) :159-165.
  • 9HUJER A M, BETHEL C R,BONOMO R A. Anti- body mapping of the linear epitopes of CMY-2 and SHV-1 β-lactamases [J]. Antimicrobial Agents and Chemotherapy, 2004,48(10) : 3980-3988.
  • 10Kotenko SV,Gallagher G,Baurin VV,et al.IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex[J].Nat Immunol,2003,4(1):69-77.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部